NG13-2 Clinical Study: MHRA Scientific Advisory Meeting on Clinical Study Design and Approval Path Gallery NG13-2 Clinical Study: MHRA Scientific Advisory Meeting on Clinical Study Design and Approval Path By Ibrahim|2025-10-07T09:24:45+00:00September 18th, 2025|News, NG13| Read More
UK MHRA Scientific Advice on Pivotal Trial of NG13-2, a Novel Product for the Prevention of Chemotherapy-Induced Alopecia Gallery UK MHRA Scientific Advice on Pivotal Trial of NG13-2, a Novel Product for the Prevention of Chemotherapy-Induced Alopecia By Jack Whitby|2025-08-07T08:27:53+00:00July 11th, 2025|News, NG13| Read More
VasoDynamics initiates NG13 optimisation development with key appointment Gallery VasoDynamics initiates NG13 optimisation development with key appointment By Chloe Atkinson|2024-12-05T11:09:11+00:00February 8th, 2024|Clinical Development, Corporate Development, News, NG13| Read More
